4DMEDICAL

Name

4DMEDICAL

Legal name

4DMedical Limited

Website

https://4dmedical.com

Company type

Public

Founded year

2012

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Medical Imaging Software

NAICS

Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391), Scientific Research and Development Services (5417)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)

akta.pro secondary industries

AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Medical Imaging AI (HDAAAEAH)

Keywords

• Functional lung imaging
• Ventilation perfusion analysis
• Respiratory imaging software
• CT ventilation mapping
• Lung density analysis

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Others

Revenue model

1. Per-scan SaaS / Usage-based Software: Cloud-based SaaS model with per-scan pricing. Commercial agreements with SimonMed Imaging and other health systems on per-scan commercial terms. Revenue recognized per scan processed through the platform.
2. Software Licenses and Subscriptions: Enterprise software licensing model for hospital deployments. Minimum order commitments from partners (e.g., Philips $10M minimum for 2026-2027).
3. Biopharma Research Services: Contract research services for pulmonary drug development. One-year GSK contract for quantitative lung imaging analytics supporting clinical research.

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels6 records

Core offering

4DMedical develops and sells AI-driven functional lung imaging software that converts routine chest CT scans and X-ray fluoroscopy into quantitative ventilation and perfusion maps, lung density analyses, and pulmonary disease diagnostic outputs. Its flagship products — CT:VQ (the first FDA-cleared non-contrast V/Q imaging solution) and XV LVAS (X-ray Velocimetry) — are sold as cloud SaaS to hospitals, outpatient imaging centers, biopharma, and government health customers. The company also distributes the XV Scanner hardware device for clinical research use and offers the Imbio and contextflow cardiothoracic and chest CT AI suites acquired in 2023 and 2026.

Product overview

4DMedical is a medical technology company offering a comprehensive cardiothoracic imaging software platform with both proprietary XV Technology and Imbio Technology. The portfolio centers on CT:VQ (FDA-cleared non-contrast ventilation-perfusion imaging) and XV LVAS (X-ray velocimetry-based lung ventilation analysis), complemented by a suite of specialized lung analysis modules including CT LVAS, LDAf, LDAi, IQ-UIP (AI-driven UIP detection), LTA, PHA, and CAC. The company also acquired Imbio (2023) and contextflow (2026) to expand capabilities and establish European commercial presence. All products are delivered as cloud-based SaaS software that analyzes routine CT or X-ray scans to provide quantitative functional lung insights without requiring additional specialized equipment.

Differentiator

Problem solved

Functional benefit

Brands

• Imbio: Medical imaging analysis technologies including CAC, IQ-UIP, LDA, LTA, PHA products for cardiothoracic imaging. A fully owned subsidiary and retained brand following acquisition in December 2023.
• CT:VQ
• XV Technology
• contextflow

Products and services

• CT:VQ — Non-Contrast Ventilation-Perfusion Imaging World's first and only FDA-cleared, CE-marked and Health Canada-cleared non-contrast ventilation-perfusion imaging software that converts routine chest CT scans into quantitative V/Q maps for functional lung assessment without radiotracers or nuclear medicine infrastructure. Used by hospitals, outpatient imaging centers, biopharma and government health customers.
• XV LVAS — X-ray Velocimetry Lung Ventilation Analysis Software Creates moving 4D images during X-ray fluoroscopy exams and uses machine-learning algorithms adapted from aerospace wind tunnel processing to quantitatively measure regional lung ventilation and produce color-coded ventilation maps. Sold to hospitals, clinical researchers, and veteran health providers.
• CT LVAS — CT Lung Ventilation Analysis Software Provides quantitative lung ventilation analysis from standard chest CT scans, validated against the gold standard PET method in peer-reviewed publications. Used by clinical imaging departments and research centers for regional lung function assessment.
• IQ-UIP — Early IPF Detection AI-driven diagnostic software that detects the Usual Interstitial Pneumonia (UIP) pattern from CT scans, the hallmark radiological pattern for diagnosing Idiopathic Pulmonary Fibrosis (IPF). FDA 510(k) cleared and intended for radiologists and pulmonologists.
• CAC — Coronary Artery Calcification Software AI-powered automated coronary artery calcium scoring from routine chest CT scans for cardiovascular risk assessment. Part of the Imbio imaging suite used by hospitals and imaging centers.
• LDAf — Functional Lung Density Analysis

Quantifiable outcome

• First and only non-contrast V/Q imaging solution with FDA 510(k) clearance
• +3 more outcomes

Named customers11 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

Partnerships

Six partnerships are on record, tiered core and minor.

• contextflow GmbHcoreStrategic or Co-development Partner · 10 June 2026Binding agreement to acquire Vienna-based medical imaging software company specializing in lung cancer detection, chest CT analysis, and radiology workflow solutions. All-share transaction with cash, shares, and performance-based options. Establishes 4DMedical's European commercial platform with CE-marked products, existing customer base, and MDR-aligned regulatory capabilities. CEO Markus Holzer becomes General Manager of Europe.
• SimonMed ImagingcoreChannel Partner/ Reseller/ Distributor · 29 May 2026Three-year commercial agreement for deployment of CT:VQ and LDAf across SimonMed's network of 170+ outpatient imaging centers in 10 U.S. states. Per-scan pricing with immediate commercial effect. SimonMed will support development of reimbursement evidence for CT:VQ across public and private payors.
• GSK (GlaxoSmithKline)coreStrategic or Co-development Partner · 2 May 2026One-year contract commencing May 2026 to provide quantitative lung imaging analytics to support pulmonary drug development and clinical research. Partnership includes Flywheel Exchange for data management. Validates growing biopharma demand for 4DMedical's imaging platform.
• PhilipscoreChannel Partner/ Reseller/ Distributor · 19 December 2025Philips distributes 4DMedical's CT:VQ across healthcare systems in U.S. and Canada through its Advanced Visualization Workspace (AVW) on HealthSuite cloud platform powered by AWS. Expanded partnership with minimum US$10 million order commitment for 2026-2027. Also featured as AI partnership at RSNA 2025 for pulmonary conditions.
• Blackford AnalysisminorChannel Partner/ Reseller/ DistributorDistribution agreement for Imbio's medical imaging AI solutions. Blackford distributes Imbio's imaging analysis software to healthcare customers.
• Adelaide University and University of MelbourneminorStrategic or Co-development PartnerResearch collaboration with Australian universities for X-ray velocimetry (XV) technology development. Project funded by Australia's Economic Accelerator to advance AI-driven functional lung imaging for cystic fibrosis, asthma, and bronchiectasis detection.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• contextflow: Vienna-based AI radiology company specializing in lung CT pattern recognition, nodule detection, and radiology workflow. Direct comparable to 4DMedical's lung CT analytics franchise and is being acquired by 4DMedical to anchor its European platform.
• Riverain Technologies: AI imaging vendor focused on chest CT and X-ray analysis for lung nodule detection, lung cancer screening, and chest radiology workflow. Closely comparable to 4DMedical's lung-focused AI radiology software portfolio targeting radiologists and pulmonologists.
• Optellum: AI platform for lung cancer detection, lung nodule management, and pulmonary decision support from CT imaging. Directly comparable to 4DMedical's lung cancer/CT analytics roadmap (especially via contextflow) and serves a similar pulmonologist/radiologist audience.
• Arterys (Tempus AI): Cloud-native AI imaging platform with FDA-cleared lung and cardiac analysis tools distributed via major PACS vendors. Comparable to 4DMedical's cloud-based, SaaS-delivered functional imaging model and its channel-led go-to-market.

Emerging players

• Aidoc: Broad radiology AI platform covering multiple body parts and modalities with enterprise hospital sales. Comparable to 4DMedical's enterprise SaaS model and per-study AI analytics, though Aidoc is more multi-organ rather than lung-specialized.
• Quibim: AI imaging analytics company offering quantitative imaging biomarkers across oncology, neurology, and chest imaging. Overlaps with 4DMedical's quantitative lung imaging and biopharma imaging biomarker use cases, particularly for clinical trial endpoints.
• Annalise.ai: Radiology AI suite with chest X-ray and CT modules covering multiple findings including lung pathology. Comparable to 4DMedical on the AI chest imaging product axis and on selling AI modules into hospital radiology workflows.

Broad incumbents

• Philips: Global medical imaging OEM with the Advanced Visualization Workspace that distributes 4DMedical's CT:VQ. Functions as both key channel partner and broad incumbent competitor in radiology AI and advanced visualization.
• GE HealthCare: Global imaging OEM (CT, X-ray, PACS) and developer of Edison AI radiology applications including lung/chest solutions. Comparable to 4DMedical as a broad incumbent in the same customer base of radiology departments and imaging centers.
• Siemens Healthineers: Imaging OEM with AI-Rad Companion and syngo.via advanced visualization, including chest CT and lung analysis tools. Comparable to 4DMedical in targeting radiology and pulmonology with embedded and standalone AI imaging software.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/4dmedical
• Xx.com/4dmedicalxv

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries5 records

Funding overview

Funding rounds4 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 4DMEDICAL